NO20004896D0 - Pyridazinonhydrokloridforbindelse og fremgangsmÕte for fremstilling derav - Google Patents
Pyridazinonhydrokloridforbindelse og fremgangsmÕte for fremstilling deravInfo
- Publication number
- NO20004896D0 NO20004896D0 NO20004896A NO20004896A NO20004896D0 NO 20004896 D0 NO20004896 D0 NO 20004896D0 NO 20004896 A NO20004896 A NO 20004896A NO 20004896 A NO20004896 A NO 20004896A NO 20004896 D0 NO20004896 D0 NO 20004896D0
- Authority
- NO
- Norway
- Prior art keywords
- preparation
- hydrochloride compound
- pyridazinone hydrochloride
- pyridazinone
- compound
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
- C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D237/22—Nitrogen and oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
- C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D237/12—Halogen atoms or nitro radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
- C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Pulmonology (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP8592098 | 1998-03-31 | ||
| PCT/JP1999/001629 WO1999050248A1 (en) | 1998-03-31 | 1999-03-30 | Pyridazinone hydrochloride compound and method for producing the same |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20004896D0 true NO20004896D0 (no) | 2000-09-29 |
| NO20004896L NO20004896L (no) | 2000-10-12 |
Family
ID=13872231
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20004896A NO20004896L (no) | 1998-03-31 | 2000-09-29 | Pyridazinonhydrokloridforbindelse og fremgangsmÕte for fremstilling derav |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US6310065B1 (no) |
| EP (1) | EP1066265A1 (no) |
| JP (1) | JP2002509919A (no) |
| KR (1) | KR20010042078A (no) |
| CN (1) | CN1293661A (no) |
| AU (1) | AU742553B2 (no) |
| CA (1) | CA2326506A1 (no) |
| IL (1) | IL138521A0 (no) |
| NO (1) | NO20004896L (no) |
| NZ (1) | NZ506959A (no) |
| SK (1) | SK14742000A3 (no) |
| TW (1) | TW499425B (no) |
| WO (1) | WO1999050248A1 (no) |
| ZA (1) | ZA200004927B (no) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7407955B2 (en) | 2002-08-21 | 2008-08-05 | Boehringer Ingelheim Pharma Gmbh & Co., Kg | 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions |
| US7501426B2 (en) | 2004-02-18 | 2009-03-10 | Boehringer Ingelheim International Gmbh | 8-[3-amino-piperidin-1-yl]-xanthines, their preparation and their use as pharmaceutical compositions |
| DE102004054054A1 (de) | 2004-11-05 | 2006-05-11 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Verfahren zur Herstellung chiraler 8-(3-Amino-piperidin-1-yl)-xanthine |
| DE102005035891A1 (de) | 2005-07-30 | 2007-02-08 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | 8-(3-Amino-piperidin-1-yl)-xanthine, deren Herstellung und deren Verwendung als Arzneimittel |
| PE20110235A1 (es) | 2006-05-04 | 2011-04-14 | Boehringer Ingelheim Int | Combinaciones farmaceuticas que comprenden linagliptina y metmorfina |
| EP1852108A1 (en) | 2006-05-04 | 2007-11-07 | Boehringer Ingelheim Pharma GmbH & Co.KG | DPP IV inhibitor formulations |
| EA030606B1 (ru) | 2006-05-04 | 2018-08-31 | Бёрингер Ингельхайм Интернациональ Гмбх | Способы приготовления лекарственного средства, содержащего полиморфы |
| PE20091730A1 (es) | 2008-04-03 | 2009-12-10 | Boehringer Ingelheim Int | Formulaciones que comprenden un inhibidor de dpp4 |
| KR20200118243A (ko) | 2008-08-06 | 2020-10-14 | 베링거 인겔하임 인터내셔날 게엠베하 | 메트포르민 요법이 부적합한 환자에서의 당뇨병 치료 |
| UY32030A (es) | 2008-08-06 | 2010-03-26 | Boehringer Ingelheim Int | "tratamiento para diabetes en pacientes inapropiados para terapia con metformina" |
| KR20110067096A (ko) | 2008-09-10 | 2011-06-21 | 베링거 인겔하임 인터내셔날 게엠베하 | 당뇨병 및 관련 상태를 치료하기 위한 병용 요법 |
| US8978895B2 (en) * | 2008-10-01 | 2015-03-17 | Rickey E. Wark | Self-cleaning coal separator grids with multiple cleaning combs |
| US20200155558A1 (en) | 2018-11-20 | 2020-05-21 | Boehringer Ingelheim International Gmbh | Treatment for diabetes in patients with insufficient glycemic control despite therapy with an oral antidiabetic drug |
| JP2012512848A (ja) | 2008-12-23 | 2012-06-07 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | 有機化合物の塩の形態 |
| AR074990A1 (es) | 2009-01-07 | 2011-03-02 | Boehringer Ingelheim Int | Tratamiento de diabetes en pacientes con un control glucemico inadecuado a pesar de la terapia con metformina |
| BR112012012641A2 (pt) | 2009-11-27 | 2020-08-11 | Boehringer Ingelheim International Gmbh | TRATAMENTO DE PACIENTES DIABÉTICOS GENOTIPADOS COM INIBIDORES DE DPP-lVTAL COMO LINAGLIPTINA |
| WO2011138421A1 (en) | 2010-05-05 | 2011-11-10 | Boehringer Ingelheim International Gmbh | Combination therapy |
| EP3366304B1 (en) | 2010-06-24 | 2020-05-13 | Boehringer Ingelheim International GmbH | Diabetes therapy |
| US9034883B2 (en) | 2010-11-15 | 2015-05-19 | Boehringer Ingelheim International Gmbh | Vasoprotective and cardioprotective antidiabetic therapy |
| WO2013010964A1 (en) | 2011-07-15 | 2013-01-24 | Boehringer Ingelheim International Gmbh | Substituted quinazolines, the preparation thereof and the use thereof in pharmaceutical compositions |
| US9555001B2 (en) | 2012-03-07 | 2017-01-31 | Boehringer Ingelheim International Gmbh | Pharmaceutical composition and uses thereof |
| WO2013171167A1 (en) | 2012-05-14 | 2013-11-21 | Boehringer Ingelheim International Gmbh | A xanthine derivative as dpp -4 inhibitor for use in the treatment of podocytes related disorders and/or nephrotic syndrome |
| WO2013174767A1 (en) | 2012-05-24 | 2013-11-28 | Boehringer Ingelheim International Gmbh | A xanthine derivative as dpp -4 inhibitor for use in modifying food intake and regulating food preference |
| ES2950384T3 (es) | 2014-02-28 | 2023-10-09 | Boehringer Ingelheim Int | Uso médico de un inhibidor de DPP-4 |
| EP3468562A1 (en) | 2016-06-10 | 2019-04-17 | Boehringer Ingelheim International GmbH | Combinations of linagliptin and metformin |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL110040A (en) * | 1993-06-29 | 2000-07-16 | Nissan Chemical Ind Ltd | Pyridazinone derivatives their preparation and pharmaceutical compositions comprising them |
| JP3080131B2 (ja) * | 1993-06-29 | 2000-08-21 | 日産化学工業株式会社 | ピリダジノン誘導体 |
-
1999
- 1999-03-30 SK SK1474-2000A patent/SK14742000A3/sk unknown
- 1999-03-30 EP EP99910776A patent/EP1066265A1/en not_active Withdrawn
- 1999-03-30 JP JP2000541153A patent/JP2002509919A/ja not_active Withdrawn
- 1999-03-30 KR KR1020007010430A patent/KR20010042078A/ko not_active Application Discontinuation
- 1999-03-30 AU AU29606/99A patent/AU742553B2/en not_active Ceased
- 1999-03-30 TW TW088105033A patent/TW499425B/zh active
- 1999-03-30 US US09/646,127 patent/US6310065B1/en not_active Expired - Fee Related
- 1999-03-30 NZ NZ506959A patent/NZ506959A/en unknown
- 1999-03-30 CN CN99804120A patent/CN1293661A/zh active Pending
- 1999-03-30 IL IL13852199A patent/IL138521A0/xx unknown
- 1999-03-30 WO PCT/JP1999/001629 patent/WO1999050248A1/en not_active Application Discontinuation
- 1999-03-30 CA CA002326506A patent/CA2326506A1/en not_active Abandoned
-
2000
- 2000-09-15 ZA ZA200004927A patent/ZA200004927B/en unknown
- 2000-09-29 NO NO20004896A patent/NO20004896L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| TW499425B (en) | 2002-08-21 |
| NO20004896L (no) | 2000-10-12 |
| IL138521A0 (en) | 2001-10-31 |
| ZA200004927B (en) | 2001-12-24 |
| SK14742000A3 (sk) | 2001-03-12 |
| KR20010042078A (ko) | 2001-05-25 |
| EP1066265A1 (en) | 2001-01-10 |
| AU742553B2 (en) | 2002-01-03 |
| CN1293661A (zh) | 2001-05-02 |
| AU2960699A (en) | 1999-10-18 |
| JP2002509919A (ja) | 2002-04-02 |
| US6310065B1 (en) | 2001-10-30 |
| WO1999050248A1 (en) | 1999-10-07 |
| NZ506959A (en) | 2002-02-01 |
| CA2326506A1 (en) | 1999-10-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20004896D0 (no) | Pyridazinonhydrokloridforbindelse og fremgangsmÕte for fremstilling derav | |
| NO20032753D0 (no) | Forbindelse og anvendelse derav | |
| NO20012158D0 (no) | Substituerte 2-fenylbenzimidazoler, fremgangsmåte til fremstilling og anvendelse derav | |
| DE69927844D1 (de) | N-substituierte 2-cyanopyrrolidine | |
| DK1454907T3 (da) | Quninazolin og pyridopyrmidin-derivativer | |
| NO20000627D0 (no) | ForhÕndsbelagte kontrollert - frigjørings - gjødningsmidler og fremgangsmÕter for deres fremstilling | |
| DK0985697T3 (da) | Oxiranderivater og fremgangsmåde til fremstilling deraf | |
| DK1180518T3 (da) | 5-pyridyl-1,3-azolforbindelser, fremgangsmåde til fremstilling deraf og anvendelse deraf | |
| DE69906554D1 (de) | P38 inhibitoren | |
| NO20003067D0 (no) | Antipicornavirus-forbindelser og fremgangsmÕter for deres anvendelse og fremstilling | |
| NO20021736D0 (no) | Nytt preparat og fremgangsmåte for stabilisering av det | |
| DK1073672T3 (da) | Antipicornavirale forbindelser, deres fremstilling og anvendelse | |
| NO20003070D0 (no) | Substituert tiazolidinderivat, fremgangsmÕte for fremstilling og anvendelse derav | |
| NO20012963D0 (no) | Fremgangsmåte for fremstilling av 3-alkanoylindoler og 3- alkylindoler | |
| EE200100383A (et) | L-fenüülefriinvesinikkloriidi valmistamise meetod | |
| NO20013237D0 (no) | 3,3-biarylpiperidin og 2,2-biarylmorfolinderivater | |
| DK1003383T4 (da) | Smagsforstærkende N-ethyl-p-menthan-3-carboxamidindeholdende forbindelser og fremgangsmåde til fremstilling og anvendelse deraf | |
| NO991278L (no) | FremgangsmÕte og system for sikker netthandel | |
| NO985248D0 (no) | Indolylpyrrolydenmetylpyrrolderivater og fremgangsmÕte for deres fremstilling | |
| DK1140952T3 (da) | Phosphororganiske forbindelser og anvendelse heraf | |
| GB0030218D0 (en) | Photographic element compound and process | |
| DE59905521D1 (de) | Spannvorrichtung | |
| NO20012099D0 (no) | Fremgangsmåte for fremstilling av 4-arylpiperidin-3- carbinoler og beslektede forbindelser | |
| NO20006479D0 (no) | Tienopyridinforbindelser, deres fremstilling og anvendelse | |
| DE59905895D1 (de) | Spannvorrichtung |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |